Article Details

Repairing the Spine: Q&A with Mike Kelly, CEO of NervGen - Pharmaceutical Executive

Retrieved on: 2024-08-21 16:07:47

Tags for this article:

Click the tags to see associated articles and topics

Repairing the Spine: Q&A with Mike Kelly, CEO of NervGen - Pharmaceutical Executive. View article details on hiswai:

Excerpt

Divergent Paths: Pharm Exec Profiles Five Recent Drug Launches · Exxua (Fabre-Kramer Pharmaceuticals) · Omvoh (Eli Lilly) · Truqap (AstraZeneca) · Wegovy ...

Article found on: www.pharmexec.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up